Mohammad Amin Doustvandi

690 citations
30 papers · 521 indexed · h-index 12
Topics
MicroRNA in disease regulation (10 papers)Circular RNAs in diseases (8 papers)Nanoplatforms for cancer theranostics (7 papers)
Journals
SHILAP Revista de lepidopterologíaFood ChemistryMolecules
Partner nations
IranUnited StatesDenmark

In The Last Decade

Mohammad Amin Doustvandi

29 papers receiving 517 citations

Peers

Mohammad Amin Doustvandi
Comparison fields: 5 of 87
  • Molecular Biology 211
  • Pulmonary and Respiratory Medicine 180
  • Biomedical Engineering 166
  • Materials Chemistry 87
  • Cancer Research 85
Replace Qin Tian with:
Qin Tian China
Forough Alemi Iran
Yufan Gu China
Maryam Nakhjavani Australia
Yu Liang China
Ruyi Li China
Jin Tae Hong South Korea
Saniya Arfin India
Peiliang Shen China
Mohammad Amin Doustvandi relative to Qin Tian China Qin Tian's profile →
Citations per field
00.5×4.1×
Qin Tian · 1×
Citations per year

Countries citing papers authored by Mohammad Amin Doustvandi

Since Specialization
Citations

This map shows the geographic impact of Mohammad Amin Doustvandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Amin Doustvandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Amin Doustvandi more than expected).

Fields of papers citing papers by Mohammad Amin Doustvandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Amin Doustvandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Amin Doustvandi. The network helps show where Mohammad Amin Doustvandi may publish in the future.

Co-authorship network of co-authors of Mohammad Amin Doustvandi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Amin Doustvandi. A scholar is included among the top collaborators of Mohammad Amin Doustvandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Amin Doustvandi. Mohammad Amin Doustvandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 7
4 5
5 1
6 5
7 8
8 2
9 10
10 4
11 13
12 9
13 1
14 19
15 15
16 11
17 18
18 32
19 174
20 39

About Mohammad Amin Doustvandi

Mohammad Amin Doustvandi is a scholar working on Cancer Research, Neurology and Molecular Biology, having authored 30 papers that have together received 521 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (8 papers) and Nanoplatforms for cancer theranostics (7 papers). The work is most often cited by research in Drug Discovery (1 citation), Cancer Research (85 citations) and Pulmonary and Respiratory Medicine (180 citations). Mohammad Amin Doustvandi has collaborated with scholars based in Iran, United States and Denmark. Frequent co-authors include Behzad Baradaran, Behzad Mansoori, Ali Mohammadi, Michael R. Hamblin, Ahad Mokhtarzadeh, Farzin Kamari, Morten F. Gjerstorff, Khalil Hajiasgharzadeh, Dariush Shanehbandi and Saeed Sadigh‐Eteghad. Their work appears in journals such as SHILAP Revista de lepidopterología, Food Chemistry and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026